MARKET

ONC

ONC

BeOne Medicines Ltd.
NASDAQ
325.13
+4.43
+1.38%
Opening 13:13 04/17 EDT
OPEN
322.33
PREV CLOSE
320.70
HIGH
328.39
LOW
322.30
VOLUME
91.89K
TURNOVER
--
52 WEEK HIGH
385.22
52 WEEK LOW
218.31
MARKET CAP
36.07B
P/E (TTM)
128.55
1D
5D
1M
3M
1Y
5Y
1D
Johnson & Johnson: Why I See Downside Ahead
Seeking Alpha · 6h ago
Here are the major earnings after the close Wednesday
Seeking Alpha · 2d ago
BeiGene Q1 2026 Earnings Preview
Seeking Alpha · 2d ago
BeOne Medicines publishes 2025 Responsible Business and Sustainability Report
PUBT · 3d ago
BeOne Medicines publishes 2025 annual report
PUBT · 3d ago
Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ), BeOne Medicines (ONC) and Helus Pharma (HELP)
TipRanks · 4d ago
Weekly Report: what happened at ONC last week (0406-0410)?
Weekly Report · 4d ago
BeOne Medicines SVP, General Counsel Henry Lee Chan disposes of shares worth $103,448
Reuters · 6d ago
More
About ONC
BeOne Medicines AG, formerly BeiGene, Ltd., is a global oncology company engaged in discovering and developing treatments for cancer patients worldwide. With a portfolio spanning hematology and solid tumors, the Company is engaged in the development of its diverse pipeline of novel therapeutics. Its products include Brukinsa, Tevimbra and Pamiparib. Brukinsa is an orally available, small-molecule inhibitor of Bruton’s tyrosine kinase (BTK). Tevimbra is a humanized immunoglobulin G4 (IgG4) anti-programmed cell death protein 1 (PD-1) monoclonal antibody with high affinity and binding specificity against PD-1. It is designed to minimize binding to Fc-gamma (Fcy) receptors on macrophages, helping the body’s immune cells detect and fight tumors. The Company’s product pipeline in development includes Sonrotoclax, Tarlatamab, Zanidatamab, Blinatumomab, BGB-26808, BGB-R046, BG-68501, BG-C9074, BGB-43395, Xaluritamig, and others.

Webull offers BeOne Medicines AG (ADR) stock information, including NASDAQ: ONC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ONC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ONC stock methods without spending real money on the virtual paper trading platform.